Results 291 to 300 of about 55,031 (326)

Isoquercetin and Zafirlukast Cooperatively Suppress Tumor Growth and Thromboinflammatory Signaling in a Xenograft Model of Ovarian Cancer

open access: yesThe FASEB Journal, Volume 40, Issue 1, 15 January 2026.
Treatment using either the thiol isomerase inhibitor isoquercetin or zafirlukast lowers tissue factor levels, decreases VEGF, inhibits PD‐L1, and TMEM176B in a xenograft model of ovarian cancer. A combination of the two agents, at threefold lower concentrations than either drug, significantly enhanced the inhibition further, suggesting a dual action of
Justine A. Keovilay   +4 more
wiley   +1 more source

An Evaluation of Osseointegration Outcomes Around Trabecular Metal Implants in Human Maxillaries Reconstructed with Allograft and Platelet-Rich Fibrin. [PDF]

open access: yesBiomimetics (Basel)
Oroumieh SI   +9 more
europepmc   +1 more source

Tooth Graft and Platelet-Rich Fibrin Mixture for Oral Bone Reconstruction and Preservation: A Scoping Review. [PDF]

open access: yesClin Exp Dent Res
Shekarian M   +5 more
europepmc   +1 more source

Efficacy of leukocyte- and platelet-rich fibrin in the treatment and prevention of medication-related osteonecrosis of the jaw: a prospective study. [PDF]

open access: yesMed Oral Patol Oral Cir Bucal
Medeiros-Monzón A   +6 more
europepmc   +1 more source

Platelet-Rich Plasma and Platelet-Rich Fibrin in Endodontics: A Scoping Review. [PDF]

open access: yesInt J Mol Sci
Rebimbas Guerreiro S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy